Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139152
Status:
COMPLETED
Last Update Posted:
2014-01-07
First Post:
2005-08-29
Brief Title:
Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair
Sponsor:
Creighton University
Organization:
Creighton University
Study Overview
Official Title:
Exhaled Breath Condensate and Nitric Oxide Non-invasive Evaluation of Lung Disease After Treatment With Xolair
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to study the effects of Xolair using non-invasive techniques from the expired gas of patients with moderate to severe allergic asthma
Detailed Description:
Traditional methods of sampling secretions from the lower respiratory tract include sputum collection sputum induction and bronchoscopy with bronchoalveolar lavage They cannot be repeated within a short period of time because of their invasiveness and because the procedures themselves may include an inflammatory response The need to monitor inflammation in the lungs has led to the exploration of exhaled gases and condensates Noninvasive monitoring may assist in differential diagnosis of pulmonary diseases assessment of disease severity and response to treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None